Skip to main content

8-K

Amphenol Corp /De/ (APH)

8-K 2022-05-18 For: 2022-05-18
View Original
Added on April 09, 2026
View as plain text

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM 8-K

CURRENT REPORT


Pursuant to Section13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):   May 18, 2022

AMPHENOL CORPORATION

(Exact name of registrant as specified in its charter)

Delaware 1-10879 22-2785165
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
358 Hall Avenue, Wallingford, Connecticut 06492
--- ---
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code:

(203

) 265-8900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Class A<br> Common Stock, $0.001 par value APH New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.07 Submission of Matters to a Vote of Security Holders.


The annual meeting of stockholders of the Company was held on May 18, 2022.  As of March 21, 2022, the record date for the meeting, 597,538,403 shares of the Company’s Class A Common Stock were outstanding.  A quorum of 544,658,520 shares were present or represented at the meeting.

The stockholders (i) elected each of the Company’s nominees for director, (ii) ratified the selection of Deloitte & Touche LLP as independent accountants of the Company, (iii) approved the advisory vote on compensation of named executive officers, and (iv) voted against a stockholder proposal regarding proxy access.  Voting of shares for each item, all of which are described in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 11, 2022, is as follows:

1. ELECTION OF DIRECTORS

FOR

the nominees:

NOMINEE FOR AGAINST ABSTAIN NON-VOTES
Nancy A. Altobello 528,350,330 1,010,120 168,368 15,129,702
Stanley L. Clark 496,281,296 33,058,158 189,364 15,129,702
David P. Falck 474,524,116 54,818,384 186,318 15,129,702
Edward G. Jepsen 504,524,738 24,818,670 185,410 15,129,702
Rita S. Lane 516,878,699 12,481,415 168,704 15,129,702
Robert A. Livingston 520,832,915 8,508,738 187,165 15,129,702
Martin H. Loeffler 510,236,710 19,075,917 216,191 15,129,702
R. Adam Norwitt 524,907,957 4,440,445 180,416 15,129,702
Anne Clarke Wolfe 520,856,064 8,503,883 168,871 15,129,702
2. RATIFICATIONOF SELECTION OF DELOITTE & TOUCHE LLP AS INDEPENDENT PUBLIC ACCOUNTANTS OF THE COMPANY
--- ---
FOR 506,808,783 AGAINST 35,723,119
--- --- --- ---
ABSTAIN 2,126,618 NON-VOTES 0
3. ADVISORY VOTE ON COMPENSATION OF NAMED EXECUTIVE OFFICERS
--- ---
FOR 463,709,461 AGAINST 65,496,740
--- --- --- ---
ABSTAIN 322,617 NON-VOTES 15,129,702
4. ADVISORY VOTE ON STOCKHOLDER PROPOSAL REGARDING SPECIAL SHAREHOLDER MEETING IMPROVEMENT
--- ---
FOR 230,094,752 AGAINST 297,812,602
--- --- --- ---
ABSTAIN 1,621,464 NON-VOTES 15,129,702

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Document Description
104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMPHENOL CORPORATION
By: /s/ Lance E. D’Amico
Lance E. D’Amico
Senior Vice President, Secretary and General Counsel

Date: May 18, 2022